Clinical Trial Update: A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months. [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating corneal endothelial cell density in dry eye disease patients treated with Miebo (perfluorohexyloctane ophthalmic solution) over 12 mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Miebo (perfluorohexyloctane ophthalmic solution)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye | Phase 4 | Status: ACTIVE_NOT_RECRUITING